Certified by Founder
Lodge
HepaRegeniX GmbH
start up
Germany
- Tübingen , Baden-Württemberg
- 16/04/2025
- Unknown
- $24,359,707
HepaRegeniX GmbH is a clinical-stage biotechnology company developing novel therapies for the treatment of acute and chronic liver diseases.
- Industry Biotechnology Research
- Website https://www.heparegenix.com/
- LinkedIn https://www.linkedin.com/company/heparegenix-gmbh/
Advance | $8,550,000 | (Feb 6, 2026)
Turnstile | $29,000,000 | (Feb 6, 2026)
Accrual | $75,000,000 | (Feb 6, 2026)
Connect Music | $80,000,000 | (Feb 6, 2026)
adaption | $50,000,000 | (Feb 6, 2026)
Cadastral | $9,500,000 | (Feb 6, 2026)
Nixtla | $16,000,000 | (Feb 6, 2026)
Nullify | $12,500,000 | (Feb 6, 2026)
Uplift360 | $8,724,008 | (Feb 6, 2026)
Fundamental | $255,000,000 | (Feb 6, 2026)
Duna | $35,365,500 | (Feb 6, 2026)
Flock AI | $6,000,000 | (Feb 6, 2026)